Lorazepam Injection
Product Images NDC 0641-6051

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Lorazepam (NDC 0641-6051). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Lorazepam Injection Usp Np 1)

Chemical structure of lorazepam, showing its benzodiazepine core with chlorine-substituted phenyl rings, a hydroxyl group, and a ketone functional group.*

FDA Label Image

Lorazepam Injection Usp Np 10

Lorazepam Injection, USP 4 mg/mL vial label from Hikma Pharmaceuticals USA Inc. The label indicates 40 mg per 10 mL with instructions for intramuscular and intravenous use, requiring dilution for IV. It includes storage instructions to refrigerate and warnings about solution discoloration or precipitate, and details preservatives used.*

FDA Label Image

Lorazepam Injection Usp Np 11

Lorazepam injection label displaying a QR code and alphanumeric identifiers including GTIN, serial number (SN), expiration date (EXP), and lot number (LOT). The label includes standardized data fields for product tracking and identification. No strength or route information is visible in this image.*

FDA Label Image

Lorazepam Injection, Usp Civ 2 mg/ml 1 mL Vial (Lorazepam Injection Usp Np 2)

Lorazepam injection label showing 4 mg/mL strength. The label includes the proprietary name Lorazepam and identifies it as an injection for intramuscular and intravenous use. The labeler is Hikma Pharmaceuticals USA Inc. The label features a predominantly white and blue color scheme with text and branding elements.*

FDA Label Image

Lorazepam Injection, Usp Civ 2 mg/ml 25 X 1 mL Vials (Lorazepam Injection Usp Np 3)

Lorazepam Injection, USP 2 mg/mL vial by Hikma Pharmaceuticals USA Inc., for intramuscular use with dilution required for intravenous use. The label indicates a 1 mL vial, storage instructions to protect from light and refrigerate, marked for prescription use only. The label also shows the National Drug Code (NDC) 0641-6048-01.*

FDA Label Image

Lorazepam Injection, Usp Civ 20 mg/10 mL (2 mg/ml) 10 mL Multiple Dose Vial (Lorazepam Injection Usp Np 4)

Label for Lorazepam Injection USP, 2 mg/mL, by Hikma Pharmaceuticals USA Inc. The label indicates intramuscular use and that dilution is required for intravenous use. It specifies storage in refrigeration and includes directions to cut the seal along a dotted line to open. The package contains 25 vials of 1 mL each. Preservatives and excipients are also listed.*

FDA Label Image

Lorazepam Injection, Usp Civ 20 mg/10 mL (2 mg/ml) 10 X 10 mL Multiple Dose Vials (Lorazepam Injection Usp Np 5)

Lorazepam Injection, USP 2 mg/mL (20 mg per 10 mL) in a 10 mL multiple dose vial. The label indicates use for intramuscular and intravenous administration with dilution required for intravenous use. Manufactured by Hikma Pharmaceuticals USA Inc.*

FDA Label Image

Lorazepam Injection, Usp Civ 4 mg/ml 1 mL (Lorazepam Injection Usp Np 6)

Lorazepam Injection, USP 20 mg per 10 mL (2 mg/mL) multiple dose vial label from Hikma Pharmaceuticals USA Inc. The label states intramuscular use and intravenous use with dilution required, includes storage instructions to refrigerate and to protect from light, and contains barcode and regulatory information along with excipient details and usage precaution.*

FDA Label Image

Lorazepam Injection, Usp Civ 4 mg/ml 25 X 1 mL Vials (Lorazepam Injection Usp Np 7)

Lorazepam Injection, USP 4 mg/mL label for a 1 mL vial by Hikma Pharmaceuticals USA Inc. It indicates the product is for intramuscular use and should be diluted for intravenous use. The label advises refrigeration, protection from light, and notes the product is prescription-only.*

FDA Label Image

Lorazepam Injection, Usp Civ 40 mg/10 mL (4 mg/ml) 10 mL Multiple Dose Vial (Lorazepam Injection Usp Np 8)

Lorazepam Injection, USP 4 mg/mL vial label by Hikma Pharmaceuticals USA Inc. This injection is for intramuscular and intravenous use, requiring dilution for intravenous administration. The label includes usage instructions, storage requirements to refrigerate, and package content of 25 vials of 1 mL each. The label also lists inactive ingredients and indicates the product is prescription only.*

FDA Label Image

Lorazepam Injection, Usp Civ 40 mg/10 mL (4 mg/ml) 10 X 10 mL Multiple Dose Vials (Lorazepam Injection Usp Np 9)

Lorazepam Injection, USP 4 mg/mL (40 mg per 10 mL) multiple dose vial label by Hikma Pharmaceuticals USA Inc. The label indicates intramuscular and intravenous use with dilution required. It also includes storage instructions to refrigerate and warnings not to use if discolored or containing precipitate.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.